avida medical limited
avida medical limited Company Information
Company Number
06009025
Next Accounts
171 days late
Shareholders
avida global limited
Group Structure
View All
Industry
Manufacture of basic pharmaceutical products
+1Registered Address
medical technologies innovation, first avenue, nottingham, NG9 1BG
Website
www.bcm-manufacturing.comavida medical limited Estimated Valuation
Pomanda estimates the enterprise value of AVIDA MEDICAL LIMITED at £3m based on a Turnover of £2.2m and 1.36x industry multiple (adjusted for size and gross margin).
avida medical limited Estimated Valuation
Pomanda estimates the enterprise value of AVIDA MEDICAL LIMITED at £27.6m based on an EBITDA of £4.8m and a 5.81x industry multiple (adjusted for size and gross margin).
avida medical limited Estimated Valuation
Pomanda estimates the enterprise value of AVIDA MEDICAL LIMITED at £1.8m based on Net Assets of £945.8k and 1.87x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Avida Medical Limited Overview
Avida Medical Limited is a live company located in nottingham, NG9 1BG with a Companies House number of 06009025. It operates in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in November 2006, it's largest shareholder is avida global limited with a 100% stake. Avida Medical Limited is a established, small sized company, Pomanda has estimated its turnover at £2.2m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Avida Medical Limited Health Check
Pomanda's financial health check has awarded Avida Medical Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
4 Strong
3 Regular
5 Weak
Size
annual sales of £2.2m, make it smaller than the average company (£30.7m)
- Avida Medical Limited
£30.7m - Industry AVG
Growth
3 year (CAGR) sales growth of -5%, show it is growing at a slower rate (3.3%)
- Avida Medical Limited
3.3% - Industry AVG
Production
with a gross margin of 36.1%, this company has a comparable cost of product (36.1%)
- Avida Medical Limited
36.1% - Industry AVG
Profitability
an operating margin of 210.7% make it more profitable than the average company (6.5%)
- Avida Medical Limited
6.5% - Industry AVG
Employees
with 6 employees, this is below the industry average (123)
- Avida Medical Limited
123 - Industry AVG
Pay Structure
on an average salary of £65.2k, the company has an equivalent pay structure (£65.2k)
- Avida Medical Limited
£65.2k - Industry AVG
Efficiency
resulting in sales per employee of £368.4k, this is equally as efficient (£377.9k)
- Avida Medical Limited
£377.9k - Industry AVG
Debtor Days
it gets paid by customers after 82 days, this is later than average (56 days)
- Avida Medical Limited
56 days - Industry AVG
Creditor Days
its suppliers are paid after 56 days, this is slower than average (35 days)
- Avida Medical Limited
35 days - Industry AVG
Stock Days
it holds stock equivalent to 57 days, this is less than average (105 days)
- Avida Medical Limited
105 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 7 weeks, this is less cash available to meet short term requirements (11 weeks)
7 weeks - Avida Medical Limited
11 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 23.9%, this is a lower level of debt than the average (44.6%)
23.9% - Avida Medical Limited
44.6% - Industry AVG
AVIDA MEDICAL LIMITED financials
Avida Medical Limited's latest turnover from December 2022 is estimated at £2.2 million and the company has net assets of £945.8 thousand. According to their latest financial statements, we estimate that Avida Medical Limited has 6 employees and maintains cash reserves of £41.1 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Aug 2017 | Aug 2016 | Aug 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 1,549,000 | 3,197,000 | 2,568,000 | 3,465,000 | 1,991,000 | 7,705,000 | 8,197,000 | 12,982,000 | 10,117,000 | 14,712,000 | 17,777,000 | 17,995,000 | 18,052,000 | |
| Other Income Or Grants | ||||||||||||||
| Cost Of Sales | 1,829,000 | 2,088,000 | 2,009,000 | 2,847,000 | 1,165,000 | 3,849,000 | 3,527,000 | 5,583,000 | 4,016,000 | 5,337,000 | 8,387,000 | |||
| Gross Profit | -280,000 | 1,109,000 | 559,000 | 618,000 | 826,000 | 3,856,000 | 4,670,000 | 7,399,000 | 6,101,000 | 9,375,000 | 9,390,000 | |||
| Admin Expenses | 16,576,000 | 1,850,000 | 6,342,000 | 860,000 | 879,000 | 2,910,000 | 3,490,000 | 4,322,000 | 2,605,000 | 3,132,000 | 2,334,000 | |||
| Operating Profit | -16,856,000 | -741,000 | -5,783,000 | -242,000 | -53,000 | 946,000 | 1,180,000 | 3,077,000 | 3,496,000 | 6,243,000 | 7,056,000 | 5,836,000 | 4,951,000 | |
| Interest Payable | 28,000 | 14,000 | 21,000 | 2,000 | 1,000 | 158,000 | 431,000 | 536,000 | 732,000 | |||||
| Interest Receivable | 7,000 | 7,000 | 2,000 | 7,000 | 14,000 | |||||||||
| Pre-Tax Profit | -16,884,000 | -755,000 | -5,797,000 | -237,000 | -52,000 | 952,000 | 1,192,000 | 3,100,000 | 3,510,000 | 6,085,000 | 6,625,000 | 5,300,000 | 4,219,000 | |
| Tax | 55,000 | -17,000 | -87,000 | 45,000 | -10,000 | -188,000 | -244,000 | -644,000 | -805,000 | -1,429,000 | -1,738,000 | -1,474,000 | -1,194,000 | |
| Profit After Tax | -16,829,000 | -772,000 | -5,884,000 | -192,000 | -62,000 | 764,000 | 948,000 | 2,456,000 | 2,705,000 | 4,656,000 | 4,887,000 | 3,826,000 | 3,025,000 | |
| Dividends Paid | 948,000 | 880,000 | 4,270,000 | |||||||||||
| Retained Profit | -16,829,000 | -772,000 | -5,884,000 | -192,000 | -62,000 | -184,000 | 68,000 | -1,814,000 | 2,705,000 | 4,656,000 | 4,887,000 | 3,826,000 | 3,025,000 | |
| Employee Costs | 81,000 | 74,000 | 1,024,000 | 3,932,000 | ||||||||||
| Number Of Employees | 2 | 2 | 1 | 2 | 2 | 36 | 131 | |||||||
| EBITDA* | -16,549,000 | -432,000 | -5,493,000 | -118,000 | -13,000 | 1,074,000 | 1,302,000 | 3,310,000 | 3,619,000 | 6,532,000 | 7,245,000 | 6,018,000 | 5,122,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Aug 2017 | Aug 2016 | Aug 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 403,908 | 500,000 | 1,205,000 | 1,321,000 | 1,453,000 | 1,186,000 | 683,000 | 781,000 | 816,000 | 1,023,000 | 1,131,000 | 1,358,000 | 1,399,000 | 1,363,000 |
| Intangible Assets | 14,391,000 | 14,416,000 | 18,356,000 | 17,085,000 | 17,085,000 | 17,085,000 | 17,085,000 | 17,085,000 | 17,085,000 | 17,085,000 | 17,085,000 | 17,085,000 | ||
| Investments & Other | ||||||||||||||
| Debtors (Due After 1 year) | ||||||||||||||
| Total Fixed Assets | 403,908 | 500,000 | 15,596,000 | 15,737,000 | 19,809,000 | 18,271,000 | 17,768,000 | 17,866,000 | 17,901,000 | 18,108,000 | 18,216,000 | 18,443,000 | 18,484,000 | 18,448,000 |
| Stock & work in progress | 224,474 | 360,000 | 406,000 | 557,000 | 407,000 | 576,000 | 552,000 | 579,000 | 498,000 | 978,000 | 736,000 | 700,000 | 686,000 | 448,000 |
| Trade Debtors | 499,918 | 155,000 | 456,000 | 269,000 | 363,000 | 497,000 | 7,000 | 10,000 | 2,000 | 126,000 | 129,000 | 311,000 | 503,000 | 308,000 |
| Group Debtors | 64,000 | 737,000 | 1,000,000 | 1,500,000 | 3,971,000 | 4,406,000 | 3,903,000 | 4,875,000 | 2,659,000 | 4,395,000 | 7,452,000 | 6,452,000 | ||
| Misc Debtors | 593 | 45,000 | 177,000 | 12,000 | 12,000 | 18,000 | 45,000 | 16,000 | 3,000 | 22,000 | 34,000 | 4,000 | 96,000 | 297,000 |
| Cash | 41,136 | 275,000 | 1,214,000 | |||||||||||
| misc current assets | 8,187 | 52,000 | ||||||||||||
| total current assets | 838,308 | 560,000 | 1,039,000 | 1,575,000 | 2,109,000 | 3,805,000 | 4,575,000 | 5,011,000 | 4,406,000 | 6,001,000 | 3,558,000 | 5,410,000 | 8,737,000 | 7,505,000 |
| total assets | 1,242,216 | 1,060,000 | 16,635,000 | 17,312,000 | 21,918,000 | 22,076,000 | 22,343,000 | 22,877,000 | 22,307,000 | 24,109,000 | 21,774,000 | 23,853,000 | 27,221,000 | 25,953,000 |
| Bank overdraft | ||||||||||||||
| Bank loan | ||||||||||||||
| Trade Creditors | 218,323 | 6,000 | 43,000 | 175,000 | 184,000 | 168,000 | 175,000 | 68,000 | 49,000 | 85,000 | 217,000 | 641,000 | 962,000 | 995,000 |
| Group/Directors Accounts | 3,511,000 | 1,994,000 | 1,977,000 | 619,000 | 433,000 | 565,000 | 1,086,000 | 570,000 | ||||||
| other short term finances | ||||||||||||||
| hp & lease commitments | ||||||||||||||
| other current liabilities | 78,140 | 371,000 | 542,000 | 349,000 | 1,077,000 | 1,059,000 | 1,257,000 | 1,714,000 | 1,229,000 | 526,000 | 950,000 | 1,611,000 | 1,072,000 | 1,113,000 |
| total current liabilities | 296,463 | 3,888,000 | 2,579,000 | 2,501,000 | 1,261,000 | 1,227,000 | 1,432,000 | 1,782,000 | 1,278,000 | 1,230,000 | 1,600,000 | 2,817,000 | 3,120,000 | 2,678,000 |
| loans | 5,518,000 | 13,470,000 | 16,470,000 | |||||||||||
| hp & lease commitments | ||||||||||||||
| Accruals and Deferred Income | ||||||||||||||
| other liabilities | ||||||||||||||
| provisions | 55,000 | 38,000 | 4,000 | |||||||||||
| total long term liabilities | 55,000 | 38,000 | 2,000 | 5,518,000 | 13,470,000 | 16,470,000 | ||||||||
| total liabilities | 296,463 | 3,888,000 | 2,634,000 | 2,539,000 | 1,261,000 | 1,227,000 | 1,432,000 | 1,782,000 | 1,280,000 | 1,230,000 | 1,600,000 | 8,335,000 | 16,590,000 | 19,148,000 |
| net assets | 945,753 | -2,828,000 | 14,001,000 | 14,773,000 | 20,657,000 | 20,849,000 | 20,911,000 | 21,095,000 | 21,027,000 | 22,879,000 | 20,174,000 | 15,518,000 | 10,631,000 | 6,805,000 |
| total shareholders funds | 945,753 | -2,828,000 | 14,001,000 | 14,773,000 | 20,657,000 | 20,849,000 | 20,911,000 | 21,095,000 | 21,027,000 | 22,879,000 | 20,174,000 | 15,518,000 | 10,631,000 | 6,805,000 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Aug 2017 | Aug 2016 | Aug 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | -16,856,000 | -741,000 | -5,783,000 | -242,000 | -53,000 | 946,000 | 1,180,000 | 3,077,000 | 3,496,000 | 6,243,000 | 7,056,000 | 5,836,000 | 4,951,000 | |
| Depreciation | 101,043 | 117,000 | 128,000 | 153,000 | 110,000 | 40,000 | 128,000 | 122,000 | 233,000 | 123,000 | 289,000 | 189,000 | 182,000 | 171,000 |
| Amortisation | 190,000 | 181,000 | 137,000 | 14,000 | ||||||||||
| Tax | 55,000 | -17,000 | -87,000 | 45,000 | -10,000 | -188,000 | -244,000 | -644,000 | -805,000 | -1,429,000 | -1,738,000 | -1,474,000 | -1,194,000 | |
| Stock | -135,526 | -46,000 | -151,000 | 150,000 | -169,000 | -3,000 | -27,000 | 81,000 | -480,000 | 242,000 | 36,000 | 14,000 | 238,000 | 448,000 |
| Debtors | 364,511 | -433,000 | -385,000 | -357,000 | -640,000 | -2,417,000 | -409,000 | 524,000 | -1,115,000 | 2,201,000 | -1,888,000 | -3,341,000 | 994,000 | 7,057,000 |
| Creditors | 212,323 | -37,000 | -132,000 | -9,000 | 16,000 | 100,000 | 107,000 | 19,000 | -36,000 | -132,000 | -424,000 | -321,000 | -33,000 | 995,000 |
| Accruals and Deferred Income | -292,860 | -171,000 | 193,000 | -728,000 | 18,000 | -655,000 | -457,000 | 485,000 | 703,000 | -424,000 | -661,000 | 539,000 | -41,000 | 1,113,000 |
| Deferred Taxes & Provisions | -55,000 | 17,000 | 38,000 | -4,000 | 4,000 | |||||||||
| Cash flow from operations | -16,278,000 | 165,000 | -6,072,000 | 770,000 | 1,842,000 | 972,000 | 953,000 | 4,932,000 | -185,000 | 5,870,000 | 9,052,000 | 3,238,000 | -1,469,000 | |
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | ||||||||||||||
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | ||||||||||||||
| Group/Directors Accounts | -3,511,000 | 1,517,000 | 17,000 | 1,977,000 | -619,000 | 186,000 | -132,000 | -521,000 | 516,000 | 570,000 | ||||
| Other Short Term Loans | ||||||||||||||
| Long term loans | -5,518,000 | -7,952,000 | -3,000,000 | 16,470,000 | ||||||||||
| Hire Purchase and Lease Commitments | ||||||||||||||
| other long term liabilities | ||||||||||||||
| share issue | ||||||||||||||
| interest | -28,000 | -14,000 | -14,000 | 5,000 | 1,000 | 7,000 | 14,000 | -158,000 | -431,000 | -536,000 | -732,000 | |||
| cash flow from financing | 1,489,000 | 3,000 | 1,963,000 | 5,000 | -183,000 | 7,000 | -657,000 | 200,000 | -5,808,000 | -8,904,000 | -3,020,000 | 20,088,000 | ||
| cash and cash equivalents | ||||||||||||||
| cash | 41,136 | -275,000 | -939,000 | 1,214,000 | ||||||||||
| overdraft | ||||||||||||||
| change in cash | 41,136 | -275,000 | -939,000 | 1,214,000 |
avida medical limited Credit Report and Business Information
Avida Medical Limited Competitor Analysis
Perform a competitor analysis for avida medical limited by selecting its closest rivals, whether from the MANUFACTURING sector, other small companies, companies in NG9 area or any other competitors across 12 key performance metrics.
avida medical limited Ownership
AVIDA MEDICAL LIMITED group structure
Avida Medical Limited has no subsidiary companies.
avida medical limited directors
Avida Medical Limited currently has 2 directors. The longest serving directors include Mr Paul Parkinson (Dec 2022) and Mr Neil Bashforth (Mar 2023).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Paul Parkinson | England | 58 years | Dec 2022 | - | Director |
| Mr Neil Bashforth | 59 years | Mar 2023 | - | Director |
P&L
December 2022turnover
2.2m
+43%
operating profit
4.7m
0%
gross margin
36.1%
-299.5%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
945.8k
-1.33%
total assets
1.2m
+0.17%
cash
41.1k
0%
net assets
Total assets minus all liabilities
avida medical limited company details
company number
06009025
Type
Private limited with Share Capital
industry
21100 - Manufacture of basic pharmaceutical products
21200 - Manufacture of pharmaceutical preparations
incorporation date
November 2006
age
19
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2022
previous names
bcm specials limited (December 2022)
boots chiropody limited (August 2008)
See moreaccountant
-
auditor
-
address
medical technologies innovation, first avenue, nottingham, NG9 1BG
Bank
-
Legal Advisor
-
avida medical limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to avida medical limited.
avida medical limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for AVIDA MEDICAL LIMITED. This can take several minutes, an email will notify you when this has completed.
avida medical limited Companies House Filings - See Documents
| date | description | view/download |
|---|
